rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Zydus Lifesciences Ltd.

532321 ZYDUSLIFE Group (A)

16 Jul,15:29
1184.60
-3.30 (-0.28%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Zydus Lifesciences Ltd.

BUYSELL
14,499 1,187.90 1,197.50 - 1,178.00 1,171.95 - 552.75 119,194.46
NSE | BSE

Zydus Lifesciences Ltd.

ZYDUSLIFE

16 Jul,15:49
1184.80
-3.20 (-0.27%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Zydus Lifesciences Ltd.

BUYSELL
890,243 1188.00 1,197.70 - 1,177.60 1,203.00 - 567.75 1,055,837,100.43

News for Zydus Lifesciences Ltd.

Zydus...
Zydus Lifesciences Gets USFDA Approval for Heart Failure Drug
Zydus Lifesciences receives USFDA approval to market Sacubitril and Valsartan tablets for chronic heart failure treatment in adults.
Jul 10, 2024 15:50
Zydus...
Zydus Lifesciences Gets USFDA Approval for BP Drug
Zydus Lifesciences receives tentative USFDA approval to market generic Azilsartan Medoxomil tablets for treating high blood pressure.
Jul 04, 2024 15:02
Zydus...
Zydus Lifesciences Gets USFDA Nod for Blood Pressure Drug
Zydus Lifesciences receives USFDA approval to market Azilsartan Medoxomil and Chlorthalidone tablets for high blood pressure treatment.
Jun 14, 2024 13:55
Zydus...
Zydus Lifesciences Gets USFDA Nod for Asthma Medication
Zydus Lifesciences has received USFDA approval to market Theophylline extended-release tablets for asthma and COPD. The drug will be manufactured in Ahmedabad SEZ.
May 22, 2024 17:31
Zydus...
Zydus Lifesciences Gets USFDA Nod for Asthma Drug
Zydus Lifesciences receives USFDA approval for its generic Theophylline extended-release tablets for treating asthma and COPD. The drug will be manufactured in Ahmedabad.
May 22, 2024 15:09

More News for Zydus Lifesciences Ltd. »

(Rs. Crore)

Financial Results of Zydus Lifesciences Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales10,818.708,731.607,981.907,790.406,347.40
Operating profit4,058.702,454.401,918.102,319.101,423.10
Interest390.70278.20134.9070.90233.90
Gross profit4,752.802,724.601,961.902,327.102,038.60
EPS (Rs)34.2115.118.3814.4213.80

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Zydus Lifesciences Ltd.

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020. Wikipedia

News for Pharmaceuticals and health care

Sebi Proposes...
Sebi Proposes Summary Proceedings for Intermediaries
Sebi proposes summary proceedings for intermediaries to expedite violations of securities laws, aiming for faster and more efficient handling of cases.
Jul 16, 2024 19:27
Kochi Water Metro...
Kochi Water Metro Model: Replicable in Kolkata, Mumbai, Guwahati, Goa
Kochi Water Metro's success paves the way for similar projects in Kolkata, Mumbai, Guwahati, and Goa, says Shipping Ministry official. Learn more about the model and its potential impact.
Jul 16, 2024 19:14
Motilal Oswal MF...
Motilal Oswal MF Sells Zomato Shares for Rs 646 Crore
Motilal Oswal Mutual Fund has sold its stake in Zomato for Rs 646 crore through an open market transaction. The shares were sold at an average price of Rs 226.85 apiece, with Axis Mutual Fund, BNP...
Jul 16, 2024 19:05
Gold and Silver...
Gold and Silver Rates Today: July 16, 2023
Get the latest gold and silver rates for July 16, 2023. Check the prices of standard gold, ornament gold and silverspot in India.
Jul 16, 2024 19:03
GVK Power Faces...
GVK Power Faces Insolvency: Loan Default Leads to NCLT Proceedings
GVK Power and Infrastructure Ltd faces insolvency proceedings after failing to repay loans to lenders, including ICICI Bank. The NCLT has appointed an interim resolution professional to manage the...
Jul 16, 2024 19:01

More News »

Top News

Sebi Proposes...
Sebi Proposes Summary Proceedings for Intermediaries
Sebi proposes summary proceedings for intermediaries to expedite violations of securities laws, aiming for faster and more efficient handling of cases.
Jul 16, 2024 19:27
IMF Upgrades...
IMF Upgrades China, India Outlook, Global Growth Tepid
The IMF is upgrading its economic outlook for China and India, but expects tepid global growth due to persistent inflation. Read more about the IMF's latest World Economic Outlook.
Jul 16, 2024 19:20
Union Budget...
Union Budget 2024-25: FM Marks Halwa Ceremony
Finance Minister Nirmala Sitharaman participated in the traditional 'halwa' ceremony, marking the final stage of Union Budget 2024-25 preparation. The budget will be unveiled on July 23 in Lok Sabha.
Jul 16, 2024 19:19
Kochi Water Metro...
Kochi Water Metro Model: Replicable in Kolkata, Mumbai, Guwahati, Goa
Kochi Water Metro's success paves the way for similar projects in Kolkata, Mumbai, Guwahati, and Goa, says Shipping Ministry official. Learn more about the model and its potential impact.
Jul 16, 2024 19:14
Motilal Oswal MF...
Motilal Oswal MF Sells Zomato Shares for Rs 646 Crore
Motilal Oswal Mutual Fund has sold its stake in Zomato for Rs 646 crore through an open market transaction. The shares were sold at an average price of Rs 226.85 apiece, with Axis Mutual Fund, BNP...
Jul 16, 2024 19:05

More Top News »

Report Card

PE Ratios
34.76
EPS (Rs.)
34.21
Sales (Rs. Cr)
3,332.40
Face Value (Rs.)
1
Net Profit Margin (%)
31.81
Last Bonus
1:2
Last Dividend(%)
300
Return on Average Equity
21.89

BSE Announcements from Zydus Lifesciences Ltd. (See all)

announcement Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate - 7 hour(s) ago
announcement Reg. 34 (1) Annual Report. - 4 day(s) ago

Compare 'Zydus Lifesciences Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,578.25
  • Compare
  • Divi's Laboratories Ltd.
  • 4,538.40
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,721.65
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,949.50
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,353.65
  • Compare
  • Max Healthcare Institute Ltd.
  • 899.95
  • Compare
  • Alkem Laboratories Ltd.
  • 5,192.70
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

I am 32 years and I have one daughter who is 2 year...

Hi, I am employed in Maldives from last one year and...

Hello Sir, I plan to invest in the following funds...

I am a Nri based in Singapore age 31 sole earner of...

Hi there, I am 34 yr old, new in market. Never...

I have hdfc small cap, multicap, flexicap funds all...

More REDIFFGURUS

RediffGurus

Money question

Hello, sirPlease tell me how to create a corps 2.5...

Zydus Lifesciences Ltd. performance snapshot

If you had invested Rs.  in Zydus Lifesciences Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Zydus Lifesciences Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Zydus Lifesciences Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Zydus Lifesciences Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close